AXIM Biotechnologies, Inc.
AXIM · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $8 | $7 | $7 | $7 |
| Enterprise Value | $10 | $9 | $7 | $9 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | $0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.001 | -0.001 | -0.002 |
| % Growth | 157.1% | 46.2% | 27.8% | – |
| Operating Cash Flow | -$1 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$0 | -$0 | -$0 |